re: chance of failing? avexa 754 on previous phase ll data achieved a 25 fold decrease in viral load on a non mutated hiv. (shire did this trial)
usually mutated is 2x as hard to kill
requires a 4 fold decrease in mutated HIV to pass phase ll
should be ok